Evidence map›Paper›PMID 35636569›Full record

ReviewAdvanced drug delivery reviews2022

Nano-bio interactions of 2D molybdenum disulfide.

Shounak Roy, Kaivalya A Deo, Kanwar Abhay Singh, Hung Pang Lee, Amit Jaiswal, Akhilesh K Gaharwar

Abstract readReview
In one paragraph

Review in Advanced drug delivery reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. 2D MoSNano convergence · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Periodic Table of Immunomodulatory Elements and Derived Two-Dimensional Biomaterials.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  8. Nano-structured strategies in combatting neurodegeneration.Frontiers in bioengineering and biotechnology · 2025
    Review
  9. Metal-based smart nanosystems in cancer immunotherapy.Exploration (Beijing, China) · 2024
    Review
  10. Article
  11. Article
  12. Polydiolcitrate-MoSACS applied materials & interfaces · 2024
    Article
  13. Review
  14. Article
  15. Chiral MoSJournal of nanobiotechnology · 2024
    Article
  16. Review
  17. Review
  18. Functionalized MoSJournal of nanobiotechnology · 2023
    Article
  19. A polydiolcitrate-MoSbioRxiv : the preprint server for biology · 2023
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shounak RoyBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX 77843, USA; School of Basic Sciences, Indian Institute of Technology - Mandi, Kamand, Mandi, Himachal Pradesh-175005, India.
Kaivalya A DeoBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX 77843, USA.
Kanwar Abhay SinghBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX 77843, USA.
Hung Pang LeeBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX 77843, USA.
Amit JaiswalSchool of Basic Sciences, Indian Institute of Technology - Mandi, Kamand, Mandi, Himachal Pradesh-175005, India. Electronic address: j.amit@iitmandi.ac.in.
Akhilesh K GaharwarBiomedical Engineering, College of Engineering, Texas A&M University, College Station, TX 77843, USA; Material Science and Engineering, College of Engineering, Texas A&M University, College Station, TX 77843, USA; Center for Remote Health Technologies and Systems, Texas A&M University, College Station, TX 77843, USA; Interdisciplinary Program in Genetics and Genomics, Texas A&M University, College Station, TX 77843, USA. Electronic address: gaharwar@tamu.edu.

Funding

Mineralomics: Designing mineral based therapeutics to control and direct cell functionDP2EB026265 · NIBIB · TEXAS ENGINEERING EXPERIMENT STATION · PI GAHARWAR, AKHILESH K. · 2017 to 2021
$2.4M
NIBIB NIH HHS DP2 EB026265
6 · The paper itself

Abstract

Two-dimensional (2D) molybdenum disulfide (MoS

Indexed as

MolybdenumNanostructuresDisulfidesHumansTissue DistributionDisulfidesMolybdenummolybdenum disulfide2D nanomaterialsCellular interactionsDrug deliveryImmunomodulationRegenerative medicineTransition metal dichalcogenides (TMDs)

Identifiers

PMID35636569
PMCPMC12861116

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.